NATCO PHARMA
Back to All Ratios
|
NATCO PHARMA Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 2.65 | 1.97 | 3.00 | 3.43 | 2.31 |
What is the latest EV/CE ratio of NATCO PHARMA ?
Year | EV/CE |
---|---|
Mar2024 | 2.65 |
Mar2023 | 1.97 |
Mar2022 | 3.00 |
Mar2021 | 3.43 |
Mar2020 | 2.31 |
How is EV/CE of NATCO PHARMA Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 2.65 | 34.52 | |
Mar2023 | 1.97 | -34.33 | |
Mar2022 | 3 | -12.54 | |
Mar2021 | 3.43 | 48.48 | |
Mar2020 | 2.31 | - |
Other Financial Ratios of NATCO PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹14,808.9 Cr | 10.7% | 5.9% | -15.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 10.7% |
5.9% |
-15.1% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses